Upstream Bioprocessing 2022

Vectors

Upstream Bioprocessing 2022

Upstream Bioprocessing 2022

Filter by ContentType

Complete system for AAV production for clinical production: part 1 – upstream

Complete system for AAV production for clinical production: part 1 – upstream

Jonathan Zmuda, Jenny England
26 October 2022
Innovator Insight
 Driving significant AAV process yield and quality improvements for systemic delivery

Driving significant AAV process yield and quality improvements for systemic delivery

Rahul Chelikani
29 August 2022
Interview
 Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

E Cameau, E Asilonu, S Bah et al
28 August 2022
Innovator Insight
 Adapting the power of density gradient separations for characterizing viral vector fullness

Adapting the power of density gradient separations for characterizing viral vector fullness

Shawn Sternisha
25 August 2022
Innovator Insight
 Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Samira Shore
29 July 2022
FastFacts
 Achieving better AAV vector productivity and product quality

Achieving better AAV vector productivity and product quality

Diane Golebiowski, Marissa Stanvick
22 July 2022
Podcast

Other editions


<< Back to Vectors channel